Home
About
Platform Technologies
Lead Programs
Team
Scientific Publications
Contact
News
More
NEWS
11/17/20
Virion Therapeutics Wins Prestigious 'Most Valued Company' at Keiretsu Forum Investor Capital Expo
10/1/18
Virion Therapeutics, LLC Announces its Inaugural Board of Directors and Scientific Advisory Board Members
9/26/18
Virion Therapeutics, LLC Raises $5 Million to Develop Checkpoint Inhibitor Powered Vaccine Therapies for Treatment of Virally Induced Infectious Diseases & Cancers
B A C K
